The week in health tech, explained in plain English.Get the free newsletter →
August 8, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

CVS Caremark Names Keith Reynolds Chief Growth Officer

By Healthcare Technology News ·

CVS Caremark, the pharmacy benefit manager owned by CVS Health, is adding Keith Reynolds as chief growth officer, according to an Aug. 7 LinkedIn post cited by Becker's Hospital Review. Chief Sales Officer Jim Fowler is transitioning into retirement.

Reynolds is an internal promotion with deep roots at the company. He spent 25 years across CVS Health and Aetna and most recently served as a chief operating officer. That continuity signals CVS wants an insider to protect and expand Caremark's client base rather than shift strategy under an outsider.

The move lands as PBMs face intense pressure. Caremark, along with rivals Express Scripts and Optum Rx, is under fire from the Federal Trade Commission, Congress, and employers over drug pricing and rebate practices. A growth chief must defend market share while the business model itself is being challenged by regulators and by newer transparent-pricing competitors. How Reynolds balances expansion with mounting political risk will be worth watching.

Sources

More in Payers

Payers

Medicaid's Rocky Summer: 6 States Signal What Comes Next

A year after HR 1, Medicaid faces looming eligibility checks and work requirements, with six states serving as bellwethers for coverage and financial impact.

Why it matters: Medicaid churn drives uncompensated care and margin pressure for hospitals while reshaping insurer enrollment ahead of 2027 rule changes.

Payers

UnitedHealthcare Tightens Reimbursement on Five Lab Tests

UnitedHealthcare is adding reimbursement limits on five lab test categories across its major plan lines, with most policies effective Sept. 1.

Why it matters: New payer limits mean more denials and documentation burden for labs and physicians ordering these tests.

Payers

Insurers Retreat From Medicare Advantage as Costs Climb

A handful of insurers are exiting or scaling back Medicare Advantage markets as rising medical costs, federal cuts, and star-rating disputes pressure profits.

Why it matters: Insurer pullbacks mean fewer plan choices for seniors and shifting payer dynamics for hospitals and medical groups.